BioSpace News Archive

Job Trends

New Manufacturing Facility of Umoja Biopharma Highlights Colorado’s Biopharma Potential

The 146,000 square foot facility will benefit Umoja Biopharma to eliminate crucial CAR-T production barriers. There’s a lot more going on, know everything here.

August 30, 2021
·
3 min read
·
BioSpace Editorial Staff
Drug Development

Bone Therapeutics Breaks After Phase III Osteoarthritis Failure

Shares of Bone Therapeutics are down more than 34% on the Euronext stock exchange after the company announced its Phase III osteoarthritis study failed to meet primary and critical secondary endpoints.

August 30, 2021
·
2 min read
·
Alex Keown
Deals

Revelation Biosciences Merges with SPAC Company to List on Nasdaq

The SPAC craze continues as San Diego-based Revelation Biosciences announced its merger with Petra Acquisition that will result in the company’s listing on the Nasdaq exchange.

August 30, 2021
·
2 min read
·
Alex Keown
Business

Endless RNA Creator Secures $440 Million to Build Gigabase Factory

Laronde has managed to secure as much as $440 million from a Series B financing round to support as many as 100 Endless RNA (eRNA) products and drug programs over the next decade.

August 30, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

New COVID-19 Variant C.1.2 Sparking International Concern

A new variant, C.1.2. is causing public health experts worldwide to keep an eye out for its presence as it seems to be more infectious and even more resistant to vaccines than other variants.

August 30, 2021
·
3 min read
·
Mark Terry
Drug Development

Regeneron and Sanofi Monopoly on Atopic Dermatitis Market May Soon End

Regeneron and Sanofi broke ground with the 2017 approval of the first biologic drug for atopic dermatitis, the most common form of eczema driven by allergic reactions.

August 30, 2021
·
3 min read
·
Kate Goodwin
Policy

JHL Co-founders Convicted of Trade Secret Theft

Two former executives of JHL Biotech were indicted on charges of orchestrating the theft of trade secrets, wire fraud exceeding $101 million, and money laundering.

August 30, 2021
·
2 min read
·
Heather McKenzie
Genetown

Biotech Company Driven by Cutting Edge Science and Patients, Not Ego

On June 26, Intellia announced the first-ever clinical data supporting the safety and efficacy of in vivo CRISPR genome editing in human patients.

August 30, 2021
·
5 min read
·
Heather McKenzie
Business

SpringWorks Teams with Dana-Farber Institute on Potential Cancer Therapy

SpringWorks has announced a research collaboration with the Dana-Farber Cancer Institute to advance its therapy development efforts for multiple myeloma and related diseases.

August 30, 2021
·
2 min read
·
Vanessa Doctor, RN
Early CureVac mRNA Work Points to Therapeutic Promise in Liver Fibrosis

The research underlines the progress being made in messenger RNA approaches, as spotlighted by the success of the mRNA vaccines against COVID-19.

August 30, 2021
·
3 min read
·
Mark Terry